World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
77
Citations
33154
World Ranking
1322
National Ranking
39

Medicine

D-Index
77
Citations
33402
World Ranking
18260
National Ranking
231

Overview

Nathan Clumeck is affiliated with the Université Libre de Bruxelles in Belgium. Their research primarily focuses on medicine, with particular attention to infectious diseases, pediatrics, perinatology and child health, pulmonary and respiratory medicine, clinical biochemistry, and hepatology.

The main topics Nathan Clumeck explores include:

  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 detection and testing
  • Infection Control and Ventilation
  • Metabolism and Genetic Disorders
  • Prenatal Substance Exposure Effects
  • Pharmacological Effects and Toxicity Studies
  • Hepatitis C virus research

Recent publications by Nathan Clumeck cover various aspects of infectious diseases and associated clinical outcomes. These papers are:

  • "Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff," 2020, Journal of Hospital Infection
  • "Observational cohort study of rilpivirine (RPV) utilization in Europe," 2022, AIDS Research and Therapy
  • "Influence of Hepatitis C Coinfection and Treatment on Risk of Diabetes Mellitus in HIV-Positive Persons," 2020, Open Forum Infectious Diseases
  • "Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe," 2025, JHEP Reports

The scientist regularly publishes in journals such as the Journal of Hospital Infection, AIDS Research and Therapy, Open Forum Infectious Diseases, and JHEP Reports.

Collaborations with frequent co-authors are notable in Nathan Clumeck's work, including partnerships with:

  • Işık Somuncu Johansen
  • David Jilich
  • Inka Aho
  • Lars Peters
  • Christoph Stephan

Best Publications

  • Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection

    Richard K. Sterling;Eduardo Lissen;Eduardo Lissen;Nathan Clumeck;Ricard Sola

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • CD4+ count-guided interruption of antiretroviral treatment.

    Wafaa El-Sadr;Wafaa El-Sadr;Jens D Lundgren;James Neaton;Fred Gordin

  • Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

    Sharon L. Walmsley;Antonio Antela;Nathan Clumeck;Dan Duiculescu

  • Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

    Roy M. Gulick;Jacob Lalezari;James Goodrich;Nathan Clumeck

  • Acquired Immunodeficiency Syndrome in Rwanda

    Philippe Van De Perre;Philippe Lepage;Philippe Kestelyn;AntonC. Hekker

  • European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults

    N Clumeck;A Pozniak;F Raffi

  • Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.

    Alfredo Alberti;Nathan Clumeck;Simon Collins;Wolfram Gerlich

  • Treatment of Toxoplasmic Encephalitis in Patients with AIDS: A Randomized Trial Comparing Pyrimethamine plus Clindamycin to Pyrimethamine plus Sulfadiazine

    B Dannemann;J A McCutchan;D Israelski;D Antoniskis

  • Isolation of aids virus from cell-free breast milk of three healthy virus carriers

    L. Thiry;S. Sprecher-Goldberger;T. Jonckheer;J. Levy

  • Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

    Antonella Castagna;Franco Maggiolo;Giovanni Penco;David Wright

  • Acquired Immunodeficiency Syndrome in African Patients

    Clumeck N;Sonnet J;Taelman H;Mascart-Lemone F

  • Comparison of Atovaquone (566C80) with Trimethoprim-Sulfamethoxazole to Treat Pneumocystis carinii Pneumonia in Patients with AIDS

    Walter W. Hughes;Gifford G. Leoung;Françoise F. Kramer;Samuel S.A. Bozzette

  • An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.

    Gilles Darcis;Anna Kula;Sophie Bouchat;Koh Fujinaga

  • A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection

    Sabine Kinloch De Loës;Bernard J. Hirschel;Bruno Hoen;David A. Cooper

  • Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study

    Amanda Mocroft;Andrew N. Phillips;Jose Gatell;Bruno Ledergerber

  • Pyrimethamine-Clindamycin vs. Pyrimethamine-Sulfadiazine as Acute and Long-Term Therapy for Toxoplasmic Encephalitis in Patients with AIDS

    C Katlama;S De Wit;E O'Doherty;M Van Glabeke

  • Maraviroc versus Efavirenz, Both in Combination with Zidovudine-Lamivudine, for the Treatment of Antiretroviral-Naive Subjects with CCR5-tropic HIV-1 Infection

    David A Cooper;Jayvant Heera;James Goodrich;Margaret Tawadrous

  • Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection

    Sophie Reuse;Miriam Calao;Kabamba Kabeya;Allan Guiguen

  • Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

    John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers

  • Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter

    David A. Cooper;Jose M. Gatell;Susanne Kroon;Nathan Clumeck

  • Treatment of Toxoplasmic Encephalitis in Patients with AIDS

    Brian Dannemann;J. Allen McCutchan;Dennis Israelski;Diane Antoniskis

Frequent Co-Authors

Stéphane De Wit
Stéphane De Wit Université Libre de Bruxelles
Jens D. Lundgren
Jens D. Lundgren Rigshospitalet
Christine Katlama
Christine Katlama Sorbonne University
Adriano Lazzarin
Adriano Lazzarin Vita-Salute San Raffaele University
José M. Gatell
José M. Gatell University of Barcelona
Andrew N. Phillips
Andrew N. Phillips University College London
Jan Gerstoft
Jan Gerstoft Rigshospitalet
David A. Cooper
David A. Cooper University of New South Wales
Andrzej Horban
Andrzej Horban Medical University of Warsaw
Peter Reiss
Peter Reiss University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their career options beyond traditional microbiology roles, several online programs offer valuable pathways in health and medical fields. Exploring the best online cahiim accredited health information management degree programs can prepare graduates for managing healthcare data and improving patient outcomes through effective information systems.

Certain certifications can also enhance your profile quickly, such as the fast online medical billing and coding certification programs, which are designed for rapid completion and help you enter the administrative side of medical services. These roles often intersect with public health and clinical microbiology when dealing with healthcare facilities.

Moreover, if you’re exploring broader options within healthcare, there are a variety of online healthcare programs that cover diverse disciplines, ranging from nursing to specialized medical sciences. This flexibility supports professionals aiming to diversify their expertise or pursue interdisciplinary careers that include microbiology insights.

Finally, public health is a critical area for microbiologists interested in community health impact. Many students benefit from enrolling in online mph programs easy to get into, which provide practical knowledge in epidemiology and disease control, complementing microbiology studies and opening doors to leadership roles in health organizations.

Best Scientists Citing Nathan Clumeck

Trending Scientists